Insulin Degludec vs Exendin-4

Head-to-head comparison of Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) and Exendin-4 (Exendin-4 (synthetic exenatide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin DegludecExendin-4
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameInsulin degludec (desB30, acylated ultra-long-acting insulin analog)Exendin-4 (synthetic exenatide)
Molecular Weight6103.9 Da4186 Da
Half-LifeMore than 25 hours2.4 hours
Amino Acids5039
Typical Dose0.1-0.2 U/kg once daily5-10 mcg twice daily
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count70001800
Research StatusApprovedClinical

Insulin Degludec Benefits

  • Ultra-long basal coverage
  • Lower day-to-day variability
  • Reduced nocturnal hypoglycemia
  • Flexible dosing time

Exendin-4 Benefits

  • beta-cell survival
  • glucose-stimulated insulin secretion
  • reduced glucolipotoxicity
  • lowered HbA1c in clinical use

Insulin Degludec Dosing

Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults

Exendin-4 Dosing

5 mcg SC twice daily for 4 weeks|increase to 10 mcg SC twice daily if tolerated|research: 0.1-1 µM in vitro or 1-10 µg/kg in animals

Insulin Degludec Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Exendin-4 Side Effects

  • nausea
  • vomiting
  • injection-site reactions

Research Overview

Insulin Degludec

Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.

Exendin-4

Exendin-4 helped establish GLP-1 receptor biology in diabetes and remains a classic beta-cell protective peptide. Preclinical studies show reduced beta-cell apoptosis, improved insulin content, and better islet function under metabolic stress.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Degludec stacks with:

Insulin LisproInsulin Aspart

Exendin-4 stacks with:

SGLT2 inhibitorsDPP-4 inhibitorsdiet and exercise
ultra-long-acting insulinbasal controllow variabilityGLP-1 agonistbeta-cell protectionincretin